ESC 365 - Fimasartan protects cardiac myocyte damage in ischemic heart diseases

HFA Premium Access

Fimasartan protects cardiac myocyte damage in ischemic heart diseases

Session: Poster Session 3 - Basic Science: Animal models and experimentation

Topic: Animal models and experimentation

Speaker: Assistant Professor B. Lim (Goesan-Gun, KR)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Assistant Professor Byung-Kwan Lim

Jungwon University, Goesan-Gun (Korea (Republic of))

0 follower

20 more presentations in this session

Distinct myocardial expression of mitochondrial regulators is associated with characteristic differences of in vivo hemodynamics in physiological and pathological left ventricular hypertrophy

Speaker: Doctor A. Olah (Budapest, HU)

An allogeneic bioengineered myocardial graft limits infarct size and improves cardiac function: pre-clinical study in the porcine myocardial infarction model

Speaker: Doctor C. Galvez-Monton (Badalona, ES)

Chronic phosphodiesterase-5 inhibition prevents the development of diabetic cardiomyopathy in a rat model of type-2 diabetes mellitus

Speaker: Professor T. Radovits (Budapest, HU)

Bicoronary infusion of nitroglycerin and atrial natriuretic peptide improves diastolic distensibility in healthy pigs.

Speaker: Doctor A. Alogna (Berlin, DE)

Intravenous administration of CoQ10 evokes increase in NO-mediated blood vessels relaxation

Speaker: Professor O. Medvedev (Moscow, RU)

Access the full session

Poster Session 3 - Basic Science: Animal models and experimentation

Speakers: Assistant Professor B. Lim, Doctor A. Olah, Doctor C. Galvez-Monton, Professor T. Radovits, Doctor A. Alogna...

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources